FOXP3 and non-small cell lung carcinoma: A lung cancer-specific meta-analysis similarly found that, in a combined cohort of 1,303 NSCLC patients across 11 studies, an increase in tumor-infiltrating FoxP3+ Tregs was associated with poor overall survival.